Heart attack patients under 60 get genetic screening for hidden cholesterol disorder

NCT ID NCT05218005

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether offering genetic screening to younger heart attack patients (under 60) can uncover hidden cases of Familial Hypercholesterolemia (FH), an inherited condition causing very high cholesterol. Researchers recruited 140 patients admitted with a heart attack and performed a research-based genetic test for FH. The goal was to see if this approach leads to more diagnoses and better cholesterol management after the heart attack.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Research-based genetic test for Familial Hypercholesterolemia
What this could lead to
If successful, this approach could help identify more people with a genetic cause of high cholesterol after a heart attack, leading to better treatment and prevention of future events.
What could go wrong
This is a small, completed study focused on diagnosis, not a treatment trial. It may not show that genetic testing improves long-term outcomes, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St.Pauls Hospital

    Vancouver, British Columbia, V6Z 1Y6, Canada

  • Vancouver General Hospital

    Vancouver, British Columbia, V5Z 1M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.